- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02035293
Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (PEP)
December 27, 2017 updated by: University Hospital, Brest
A standardized diagnostic strategy of pulmonary embolism will be applied to eligible patients, incorporating a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a multidetector-row CT angiography thoracic and venous ultrasound of the lower limbs.
All the patient with a pulmonary embolism diagnosed or not, will be followed for 3 months.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
750
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France
- CHU
-
Brest, France, 29200
- CHRU de Brest
-
Brest, France, 29240
- HIA
-
Clermont-Ferrand, France, 63003
- CHU Clermont-Ferrand
-
Paris, France, 75015
- Hôpital Européen Georges Pompidou
-
Quimper, France, 29107
- CH de Cornouaille Quimper
-
St-Etienne, France, 42055
- Hôpital Nord
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients hospitalized for a COPD exacerbation
- COPD previously diagnosed
Exclusion Criteria:
- Allergy to iodinated contrast
- Creatinine clearance < 30 mL / min
- Patient hospitalized for exacerbation of COPD for more than 48 hours
- Pneumothorax
- Exams impossible to be performed
- Pregnancy
- Life expectancy < 3 months
- Patients already receiving anticoagulant therapy for another reason (mechanical valve, cardiac arrhythmia).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: PEP
No drug and no placebo were used in this study.
For all the patients who participated at the study PEP, only following exams must be performed: a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a chest multidetector-row CT angiography and venous ultrasound of the lower limbs
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Frequency of pulmonary embolism in patients hospitalized for a clinical exacerbation of COPD.
Time Frame: 27 months
|
27 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The rate of pulmonary embolism diagnosed during the 3 month follow-up in patients whom pulmonary embolism was initially excluded when they've been included in the study
Time Frame: 27 months
|
27 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Francis COUTURAUD, PU-PH, CHRU de Brest
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2014
Primary Completion (Actual)
October 13, 2017
Study Completion (Actual)
October 13, 2017
Study Registration Dates
First Submitted
January 3, 2014
First Submitted That Met QC Criteria
January 13, 2014
First Posted (Estimate)
January 14, 2014
Study Record Updates
Last Update Posted (Actual)
December 29, 2017
Last Update Submitted That Met QC Criteria
December 27, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEP
- RB 13-087 [CHRU Brest]
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on PEP
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Centers for Disease Control and PreventionUniversity of Illinois, Center on Health Promotion Research for Persons with...CompletedObesityUnited States
-
Linkoeping UniversityCompletedAcute Respiratory Distress Syndrome
-
DSM Food SpecialtiesCompleted
-
Christopher J. McLeodRion LLCEnrolling by invitationPercutaneous Coronary InterventionUnited States
-
University Medical Center GroningenNot yet recruiting
-
Cliniques universitaires Saint-Luc- Université...CompletedPulmonary Disease, Chronic ObstructiveBelgium
-
Hospital de GranollersCompleted
-
Nova Scotia Health AuthorityDalhousie University; Queen Elizabeth II Health Sciences CentreCompleted
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan